The cost-effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain
| Image |  |
|---|---|
| Description | scientific article published on 29 September 2020 |
| Author/s |
author: Pablo Rebollo |
| Publication date | September 29, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |